Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 6 44-6, 1998, Pages

  Fleming, Eric F ^a   Athirakul, Krairek ^b   Oliverio, Michael I ^b   Key, Mikelle ^a   Goulet, Jennifer ^a   Koller, Beverly H ^a   Coffman, Thomas M ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Eicosanoids; Gene targeting; Kidney; Vasopressin

Indexed keywords

INDOMETACIN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; GENE TARGETING; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; MOUSE; NONHUMAN; OSMOLALITY; OSMOREGULATION; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0032426661     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.6.f955     Document Type: Article

References (34)

1. Abramow, M., R. Beauwens, and E. Cogan. Cellular events in vasopressin action. Kidney Int. Suppl. 32: S56-S66, 1987.
2. Berl, T., A. Raz, H. Wald, J. Horowitz, and W. Czaczkes. Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am. J. Physiol. 232 (Renal Fluid Electrolyte Physiol. 1): F529-F537, 1977.
3. Bonvalet, J., P. Pradelles, and N. Farman. Segmental synthesis and actions of prostaglandins along the nephron. Am. J. Physiol. 253 (Renal Fluid Electrolyte Physiol. 22): F377-F387, 1987.
4. Breyer, M., H. Jacobson, and R. Breyer. Functional and molecular aspects of renal prostaglandin receptors. J. Am. Soc. Nephrol. 7: 8-17, 1996.
5. 3 receptor. Kidney Int. 44: 1372-1378, 1993.
6. 2 and vasopressin interactions in the collecting duct. Kidney Int. 38: 618-624, 1990.
7. Chou, S.-Y., J. Porush, and P. Faubert. Renal medullary circulation: hormonal control. Kidney Int. 37: 1-13, 1990.
8. Coleman, R., W. Smith, and S. Narumiya. International Union of Pharmacology Classification of Prostanoid Receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
9. Davies, P., P. Bailey, M. Goldenberg, and A. Ford-Hutchinson. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2: 335-357, 1984.
10. Dombrowitz, D., V. Flammand, K. Brigman, B. Koller, and J.-P. Kinet. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 75: 969-976, 1993.
11. Dunn, M., and V. Hood. Prostaglandins and the kidney. Am. J. Physiol. 233 (Renal Fluid Electrolyte Physiol. 2): F169-F184, 1977.
12. 1 on the permeability response of the isolated collecting tubule to vasopres-sin, adenosine 3′,5′-monophosphate, and theophylline. J. Clin. Invest. 47: 1154-1161, 1968.
13. 2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J. Clin. Invest. 87: 1992-1998, 1991.
14. 2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F643-F650, 1993.
15. 2 synthesis in superfused cortical collecting tubules. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F1044-F1050, 1989.
16. Kirschenbaum, M., A. Lowe, W. Trizna, and L. Fine. Regulation of vasopressin action by prostaglandins. J. Clin. Invest. 70: 1193-1204, 1982.
17. 3 receptor subtype gene (PTGER3). Genomics 40: 425-434, 1997.
18. Lassiter, W., and C. Gottschalk. Regulation of water balance: urine concentration and dilution. In: Diseases of the Kidney (5th ed.), edited by R. Schrier and C. Gottschalk. Boston, MA: Little, Brown, 1992, p. 119-135.
19. Mitnick, P., A. Greenberg, W. DeOreo, K. Werner, T. Coffman, B. Walker, Z. Agus, and S. Goldfarb. Effects of two non-steroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney. Clin. Pharmacol. Ther. 28: 680-689, 1980.
20. Mohn, A., and B. Koller. Genetic manipulation of embryonic stem cells. In: DNA Cloning 4, edited by D. Glover and B. Hames. New York: Oxford University Press, 1995, p. 143-184.
21. 3 determines G-protein specificity. Nature 365: 166-170, 1993.
22. 2 regulates cAMP production in cultured rabbit CCD cells: evidence of dual inhibitory mechanisms. Am. J. Physiol. 263 (Cell Physiol. 32): C1208-C1215, 1992.
23. 2 formation. N. Engl. J. Med. 319: 689-698, 1988.
24. Schlondorff, D. Renal complications of nonsteroidal antiinflammatory drugs. Kidney Int. 44: 643-653, 1993.
25. Smith, W. Prostanoid biosynthesis and mechanism of action. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F181-F191, 1992.
26. Sonnenburg, W., and W. Smith. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins. J. Biol. Chem. 263: 6155-6160, 1988.
27. Sonnenburg, W., J. Zhu, and W. Smith. A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. J. Biol. Chem. 265: 8479-8483, 1990.
28. 3 subtype. J. Biol. Chem. 267: 6463-6466, 1992.
29. Sugimoto, Y., T. Namba, R. Shigemoto, M. Negishi, A. Ichikawa, and S. Narumiya. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F823-F828, 1994.
30. 3 receptor with different carboxyl-terminal domains. J. Biol. Chem. 268: 2712-2718, 1993.
31. 3 receptor derived by alternative RNA splicing: intrarenal expression co-localization. Biochem. Biophys. Res. Commun. 199: 834-840, 1994.
32. 3 subtype. Biochem. Biophys. Res. Commun. 203: 1897-1903, 1994.
33. 2 receptor mRNA along mouse nephron segments by RT-PCR. Am. J. Physiol. 266 (Cell Physiol. 35): C1453-C1458, 1994.
34. 2 on vasopressindependent cell cAMP in isolated single nephron segments. Am. J. Physiol. 245 (Renal Fluid Electrolyte Physiol. 14): F58-F66, 1983.